Pharmaceuticals
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. 
Subscribe to this data using MyMedWorm.
Subscribe to this data using GoogleReader.
Subscribe to this data using Bloglines.
Subscribe to this data using MyYahoo.
Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.
This page shows you the most recent publications within this specialty of the MedWorm directory. This is page number 8.
Cephalon, Barr Settle Fentora Dispute
Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
From Associated Press (November 12, 2009)
NEW YORK (AP) -- Cephalon Inc. will give Barr Pharmaceuticals
Inc. a license to sell a generic version of the pain drug Fentora
in 2018 as part of a patent lawsuit settlement, according to a
Securities and...
Source: Drugs.com - Pharma News - November 13, 2009 Category: Pharmaceuticals Source Type: news
Dr. Steven M. Paul to Retire from Lilly as Executive Vice President, Science and Technology, President, Lilly Research Laboratories; Dr. Jan M. Lundberg, Executive Vice President, Head of Global Discovery Research, AstraZeneca, Named his SuccessorEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
INDIANAPOLIS, Nov. 13 (HSMN NewsFeed) -- Eli Lilly and Company (NYSE: LLY ) announced today that Steven M. Paul, M.D., executive vice president, science and technology, and president, Lilly Research Laboratories, will retire from Lilly effective February... Biopharmaceuticals, PersonnelEli Lilly
Source: HSMN NewsFeed - November 13, 2009 Category: Pharmaceuticals Source Type: news
Misonix Announces New Distribution Agreement For The United Arab Emirates (UAE)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
FARMINGDALE, N.Y., Nov. 13 (HSMN NewsFeed) -- Misonix, Inc. (Nasdaq: MSON ), a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, has e... Devices, Surgery, DistributionMisonix, Xenith, SonaStar, BoneScalpel, SonicOne, ultrasonic aspirator
Source: HSMN NewsFeed - November 13, 2009 Category: Pharmaceuticals Source Type: news
Advances in Radiation Therapy Enable Doctors to Improve the Quality of Treatments for Patients With Head and Neck CancerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Noted clinical experts detail recent developments at the annual ASTRO meeting in Chicago
PALO ALTO, Calif., Nov. 13 (HSMN NewsFeed) -- Clinical studies suggest that advanced treatments like intensity-modulated radiotherapy (IMRT) and image-guided radi... Devices, OncologyVarian Medical Systems, image-guided radiotherapy, IGRT, radiotherapy
Source: HSMN NewsFeed - November 13, 2009 Category: Pharmaceuticals Source Type: news
Phase II/III Clinical Study Compares Safety and Efficacy of Two Doses of ZENPEP(TM) (Pancrelipase) Delayed-Release Capsules for Fat Absorption in Adult Chronic Pancreatitis Patients With Exocrine Pancreatic InsufficiencyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
PHILADELPHIA, PA - (HSMN NewsFeed) - Eurand N.V. (NASDAQ:EURX ), a global specialty pharmaceutical company, today announced data from a Phase II/III clinical study demonstrating that ZENPEP(TM) (pancrelipase) Delayed-Release Capsules significantly improves... BiopharmaceuticalsEurand, ZENPEP, pancrelipase, exocrine pancreatic insufficiency, pancreatitis
Source: HSMN NewsFeed - November 13, 2009 Category: Pharmaceuticals Source Type: news
Google Helps You Find A Flu ShotEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
From TechwebNews.com (November 12, 2009)
(TechwebNews.com ) - Google Flu Shot Finder With flu vaccines in
short supply, Google is stepping up to help people find places to
get immunized by launching a flu shot finder application for Google
Maps.
Flu...
Source: Drugs.com - Pharma News - November 13, 2009 Category: Pharmaceuticals Source Type: news
Eli Lilly Hires Paul as Chief ResearcherEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
From Associated
Press (November 13, 2009)
NEW YORK (AP)-Lilly & Co. said Friday its science and
technology head will retire. The drug maker hired the chief
researcher at AstraZeneca PLC to replace him.
Lilly said Steven Paul will retire on Feb....
Source: Drugs.com - Pharma News - November 13, 2009 Category: Pharmaceuticals Source Type: news
Drug Companies to Fight Neglected DiseasesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
By the UPI
Nov. 13, 2009
Officials at U.S. drug companies and non-profit organizations
say they plan to develop new drugs for "neglected" diseases.
The search for drugs to fight hard-to-treat diseases such as
malaria, tuberculosis and dengue fever...
Source: Drugs.com - Pharma News - November 13, 2009 Category: Pharmaceuticals Source Type: news
Yaz and Yasmin Birth Control Lawsuits Continue to MountThe Onder Law Firm Will Provide a Free Case Review to Women Suffering from Yaz Side EffectsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
It is estimated that legal counsel already represents over 3,500 women and countless others are still in need of help, unaware of their rights, if Yaz, the most popular birth control pill in the United States, affected them adversely. The Onder Law Firm will provide a free case review to women or the families of women who have suffered from serious health problems after taking Yaz. (PRWeb Nov 13, 2009)
Read the full story at http://www.prweb.com/releases/yaz/lawsuits/prweb3195174.htm
Source: PRWeb: Medical Pharmaceuticals - November 13, 2009 Category: Pharmaceuticals Source Type: news
Ryogen is Awarded New PatentEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Patented DNA Sequence Encodes a Protein Implicated in Diabetes, Metabolic Syndrome, Immune Dysfunctions and Other Diseases (PRWeb Nov 13, 2009)
Read the full story at http://www.prweb.com/releases/2009/11/prweb3191974.htm
Source: PRWeb: Medical Pharmaceuticals - November 13, 2009 Category: Pharmaceuticals Source Type: news
PhysioGenix Names Dr. Magdalena Alonso-Galicia as Senior Study DirectorEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Dr. Alonso-Galicia brings eight years of experience at Merck to PhysioGenix, expands cardiovascular and metabolic preclinical research expertise. (PRWeb Nov 13, 2009)
Read the full story at http://www.prweb.com/releases/2009/11/prweb3192684.htm
Source: PRWeb: Medical Pharmaceuticals - November 13, 2009 Category: Pharmaceuticals Source Type: news
Promega HaloTag® Protein Purification System Makes it Easier to Purify Difficult-to-Express ProteinsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Promega Corporation announces recently released HaloTag® Protein Purification System that addresses common problems associated with purification of recombinant proteins by enabling the delivery of soluble, functional recombinant target proteins at higher yield and purity. (PRWeb Nov 12, 2009)
Read the full story at http://www.prweb.com/releases/promega/halotag/prweb3191674.htm
Source: PRWeb: Medical Pharmaceuticals - November 13, 2009 Category: Pharmaceuticals Source Type: news
Webcast Auction Today with Great Deals on Lab/Pharma EquipmentEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
EquipNet is hosting a webcast auction of premium, pre-owned lab and pharmaceutical equipment today, November 12, 2009. Identified as surplus to ongoing operations at Adolor Corporation and Inspire Pharmaceuticals, the late-model equipment represents a significant cost savings over buying the equivalent, new items directly from the manufacturer. (PRWeb Nov 12, 2009)
Read the full story at http://www.prweb.com/releases/2009/11/prweb3197764.htm
Source: PRWeb: Medical Pharmaceuticals - November 13, 2009 Category: Pharmaceuticals Source Type: news
Merge Healthcare to sell 9 million sharesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Merge Healthcare said it is offering to sell up to 9,034,033 shares of common stock at $3 per share with proceeds going to pay debt held by the company’s chairman and largest shareholder. (MRGE)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 13, 2009 Category: Pharmaceuticals Source Type: journals
Cytomedix Appoints Dr. Craig Mendelsohn to Board of DirectorsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ROCKVILLE, Md., Nov. 13, 2009 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, today announced the appointment of Craig B. Mendelsohn, M.D., J.D. to the Company's Board of Directors, increasing the number of board members to seven.
Source: Medical News (via PRIMEZONE) - November 13, 2009 Category: Pharmaceuticals Source Type: news
MAKO Surgical Corp. (MAKO) to Ring The NASDAQ Stock Market Opening BellEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ADVISORY, Nov. 13, 2009 (GLOBE NEWSWIRE) --
Source: Medical News (via PRIMEZONE) - November 13, 2009 Category: Pharmaceuticals Source Type: news
Millar Instruments and Harvard Apparatus Improve Ability to Provide Customers With Total Physiology Solutions Through Joint Distribution AgreementEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ORLANDO, Fla., Nov. 13 (HSMN NewsFeed) -- Millar Instruments, Inc. developer and manufacturer of Mikro-Tip® pressure transducer catheters and pressure-volume (P-V) systems and Harvard Apparatus, manufacturer of specialty life science equipment, today... Devices, DistributionMillar Instruments, Harvard Apparatus, Mikro-Tip, pressure transducer
Source: HSMN NewsFeed - November 13, 2009 Category: Pharmaceuticals Source Type: news
Ipsen's Decapeptyl(R) 6-Month Formulation Receives Marketing Authorization in France for the Treatment of Locally Advanced or Metastatic Prostate CancerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
PARIS--(HSMN NewsFeed)--Ipsen (Paris:IPN), an innovation-driven global specialty pharmaceutical Group announces that the French regulatory authorities (Agence Française de Sécurité Sanitaire des Produits de Santé, AFSSAPS) have ... Biopharmaceuticals, Oncology, RegulatoryIpsen , Decapeptyl, triptorelin, prostate cancer
Source: HSMN NewsFeed - November 13, 2009 Category: Pharmaceuticals Source Type: news
Dr. Steven M. Paul to Retire from Lilly as Executive Vice President, Science and Technology, President, Lilly Research Laboratories; Dr. Jan M. Lundberg, Executive Vice President, Head of Global Discovery Research, AstraZeneca, Named his SuccessorEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
INDIANAPOLIS, Nov. 13 /PRNewswire-FirstCall/ -- Eli Lilly and
Company (NYSE:LLY) announced today that Steven M. Paul,
M.D., executive vice president, science and technology, and
president, Lilly Research Laboratories, will retire from...
Source: Drugs.com - Pharma News - November 13, 2009 Category: Pharmaceuticals Source Type: news
Texas Children’s patient gets heart pumpEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Texas Children’s Hospital reported this week that it became the nation’s first pediatric hospital to discharge a child with an artificial heart pump.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 13, 2009 Category: Pharmaceuticals Source Type: journals
BioInvent Signs Licensing Agreement with Daiichi Sankyo for the Discovery and Development of Therapeutic AntibodiesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Lund, Sweden – 13 November 2009 - BioInvent International
AB (OMXS: BINV) has announced that it has entered into a licence
and discovery agreement with DAIICHI SANKYO COMPANY, LIMITED (TSE:
4568) for the development of therapeutic antibodies...
Source: Drugs.com - Pharma News - November 13, 2009 Category: Pharmaceuticals Source Type: news
Astex Announces Strategic Drug Discovery Alliance with GlaxoSmithKlineEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Cambridge, UK, 12th November 2009. Astex Therapeutics Limited
announced today that it has entered into a new collaboration
agreement with GlaxoSmithKline (GSK) to discover, develop and
commercialise novel compounds directed against multiple...
Source: Drugs.com - Pharma News - November 13, 2009 Category: Pharmaceuticals Source Type: news
BioTime CEO Dr. Michael West to Present at Stem Cells USA & Regenerative Medicine Congress 2009Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ALAMEDA, Calif.--(BUSINESS WIRE)--Nov 12, 2009 - BioTime, Inc.
(NYSE Amex: BTIM) Chief Executive Officer Michael West, Ph.D. will
give two presentations at the
Stem Cells USA & Regenerative Medicine Congress 2009 to be
held at The Westin...
Source: Drugs.com - Clinical Trials - November 13, 2009 Category: Pharmaceuticals Source Type: clinical trials
Trading Outlook for Hard To Treat Diseases Inc. Issued by InvestorSoup.comEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
DALLAS, Nov. 13, 2009 (GLOBE NEWSWIRE) -- InvestorSoup.com announces an investment report featuring Hard To Treat Diseases Inc. (Pink Sheets:HTDS). The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.
Source: Medical News (via PRIMEZONE) - November 13, 2009 Category: Pharmaceuticals Source Type: news
Layoffs Sting Big PharmaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Merger-related cuts at Merck and Pfizer show how the mighty drug industry has fallen.
Source: Forbes.com Healthcare News - November 13, 2009 Category: Pharmaceuticals Source Type: news
Deflection Monitor From Eriez® Protects Vibratory Feeders And Conveyors By Detecting Overflow Material And Damaged ComponentsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The Deflection Monitor from Eriez ® intelligently tracks the operation of vibratory feeders and conveyors to prevent any damage during operation. The unit can detect abnormal amounts of material on vibratory trays or when some feeder components are failing.
Source: Pharmaceutical Online News - November 13, 2009 Category: Pharmaceuticals Source Type: news
Collaborative Work Employs Complementary Particle Characterization Tools For Inhaler DevelopmentEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
At Drug Delivery to the Lungs 20 (DDL 20), which takes place from 9 to 11 December 2009, in Edinburgh, Scotland, specialists from Malvern Instruments will present the results of work undertaken in collaboration with the Helsinki University of Technology.
Source: Pharmaceutical Online News - November 13, 2009 Category: Pharmaceuticals Source Type: news
Qlucore Expands its Marketing Efforts with New High-Profile Appointment to BoardEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Qlucore, a world leader in the development of bioinformatics software, has appointed Pia Gideon, the former vice-president of marketing and communication at Ericsson, to its board of directors.
"Qlucore is now ready for the next phase of expansion, and we are thrilled to have Pia Gideon joining us, as we know that Qlucore will benefit from her extensive experience in global marketing and communications," says Cecilia Schelin Seidegård, chairman of the board.
Qlucore is best known for its highly intuitive Qlucore Omics Explorer product, which enables instant analysis and adds i...
Source: Drug Development Technology - November 13, 2009 Category: Pharmaceuticals Source Type: info
Pharma's Fourth Hurdle - Market AccessEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Getting regulatory agency approval for a new drug was once the end goal of pharmaceutical drug development, but in today's healthcare environment where governments increasingly determine price and the availability of drugs to patients through formulary designation, market access has become the "fourth hurdle" in successfully bringing a drug to market.
Source: Pharma Industry News From Medical News Today - November 13, 2009 Category: Pharmaceuticals Tags: Pharma Industry / Biotech Industry Source Type: news
Brandjacking Index: Online Risks in Pharmaceutical MarketEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Buying drugs online continues to be fraught with fraudsters and continues to be popular because of the high demand for inexpensive medicines. While tracking six different drug brands in July 2009, four of which were patented, MarkMonitor observed continued growth in the online market for pharmaceuticals including high levels of traffic to suspicious online pharmacies and increased numbers of listings for pharmaceuticals on B2B exchange sites.
Source: PharmaManufacturing.com - November 13, 2009 Category: Pharmaceuticals Authors: Pharma Manufacturing Source Type: info
FDA Warns Five Genzyme Drugs ContaminatedEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: PharmaManufacturing.com - November 13, 2009 Category: Pharmaceuticals Authors: Pharma Manufacturing Source Type: info
Notes from ISPE: At Abbott, Leveraging PAT for the Entire API Life CycleEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Abbott has developed an entire lifecycle of API process understanding, but not without tremendous effort and coordination of formulation, development, and manufacturing teams.
Source: PharmaManufacturing.com - November 13, 2009 Category: Pharmaceuticals Authors: Pharma Manufacturing Source Type: info
PharmaView: QbD: Let the Demystification BeginEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Mock Quality by Design implementation case studies will soon be here. Like concept cars, they offer a tantalizing glimpse into the future of drug development.
Source: PharmaManufacturing.com - November 13, 2009 Category: Pharmaceuticals Authors: Pharma Manufacturing Source Type: info
Researchers Make Recommendations For Minimizing Harm And Maximizing Benefits Of Drug AdsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
While the debate over prescription drug advertising persists, a new study released online in the American Journal of Public Health offers guidelines for improving drug ads in order to minimize potential harm and maximize benefits. The study reveals that while there are some benefits from prescription drug direct-to-consumer advertising (DTCA), there are significant risks that are magnified by the prominence of DTCA.
Source: Pharma Industry News From Medical News Today - November 13, 2009 Category: Pharmaceuticals Tags: Pharmacy / Pharmacist Source Type: news
TET Systems And Novo Nordisk Sign License AgreementEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
TET Systems Holding GmbH & Co. KG ("TET Systems"), a worldwide leader in controlled gene expression, today announced that TET Systems and Novo Nordisk A/S have signed a license agreement allowing the Hagedorn Research Institute (HRI), a research institute within Novo Nordisk A/S, the use of the Tet Technology for its internal research activities.
Source: Pharmaceutical Online News - November 13, 2009 Category: Pharmaceuticals Source Type: news
Genzyme Issues Letters To U.S. Healthcare ProvidersEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Genzyme Corp. announced recently that it has issued letters to U.S. healthcare providers regarding its enzyme replacement products Cerezyme (imiglucerase for injection), Fabrazyme (agalsidase beta), Myozyme (alglucosidase alfa), Aldurazyme (laronidase), as well as Thyrogen (thyrotropin alfa for injection), filled at its Allston Landing manufacturing facility.
Source: Pharmaceutical Online News - November 13, 2009 Category: Pharmaceuticals Source Type: news
Drugs.com Refutes Erroneous ClaimsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
This week in Washington, D.C. saw the public hearings on promotion of FDA-regulated medical products using the internet and social media tools. Drugs.com got a mention and a reference or two by one of the speakers. People heard, wrote, tweeted,...
Source: Drugs.com - Pharma News - November 13, 2009 Category: Pharmaceuticals Source Type: news
Abortion Upends Health-Bill AllianceEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The last thing Democrats need right now is a fight over health care with a powerful group that ought to be an ally, yet that's what may be taking shape with the nation's Catholic bishops.
Source: WSJ.com: Health - November 13, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Sen. Reid Weighs Rise in Medicare TaxEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Senate Majority Leader Harry Reid is considering a proposal to raise Medicare payroll taxes on couples who make more than $250,000 a year.
Source: WSJ.com: Health - November 13, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Number of Insured Varies by BillEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
When the Senate unveils its health-care bill, all eyes will be on the price tag. But an equally significant number may be how many people get insurance under the legislation.
Source: WSJ.com: Health - November 13, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Swine Flu Sickens 22 Million AmericansEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
An estimated 22 million Americans have been sickened with swine flu since April and 3,900 have died, as vaccine shipments fell behind government predictions.
Source: WSJ.com: Health - November 13, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Downward Trend in Smoking Rate StallsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The battle to get adult smokers in the U.S. to quit has stalled, federal health officials warned, citing data showing a slight increase in smoking rates last year.
Source: WSJ.com: Health - November 13, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Health-Bill Disclosure Rule Is ResistedEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Health legislation moving through Congress would force drug makers to disclose how much they spend on continuing medical education classes for doctors, sparking some resistance from the industry.
Source: WSJ.com: Health - November 13, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Number of Insured Varies by BillEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
When the Senate unveils its health-care bill, all eyes will be on the price tag. But an equally significant number may be how many people get insurance under the legislation.
Source: WSJ.com: Health - November 13, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Downward Trend in Smoking Rate StallsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The battle to get adult smokers in the U.S. to quit has stalled, federal health officials warned, citing data showing a slight increase in smoking rates last year.
Source: WSJ.com: Health - November 13, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Scoring Bills by Number InsuredEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
When the Senate unveils its health-care bill, all eyes will be on the price tag. But an equally significant number may be how many people get insurance under the legislation.
Source: WSJ.com: Health - November 13, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Red Cross Faulted Over Blood SupplyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The FDA said it has found widespread and persistent problems with the storage and distribution of blood supplies by the American Red Cross.
Source: WSJ.com: Health - November 13, 2009 Category: Pharmaceuticals Tags: PAID Source Type: news
Swine Flu Sickens 22 Million AmericansEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
An estimated 22 million Americans have been sickened with swine flu since April and 3,900 have died, as vaccine shipments fell behind government predictions.
Source: WSJ.com: Health - November 13, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Abortion Upends Health-Bill AllianceEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The last thing Democrats need right now is a fight over health care with a powerful group that ought to be an ally, yet that's what may be taking shape with the nation's Catholic bishops.
Source: WSJ.com: Health - November 13, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
